# US 2023/0265488 A1 · Compositions and methods for use with fixed samples

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0265488 A1
- Document ID: US20230265488A1
- Status: Published application
- Kind: A1
- Application number: 18/046,457
- Filed: 2022-10-13
- Published: 2023-08-24
- Earliest claimed: 2020-04-16
- Assignees: 10x Genomics, Inc.
- Applicants: 10x Genomics, Inc.
- Inventors: Shalini V. Gohil; Luigi Jhon Alvarado Martinez; Albert Dale Kim
- Web page: https://patentgrep.com/patent/US20230265488A1

## CPC

- C12N 15/1096: {cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR}
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Q 1/6804: Nucleic acid analysis using immunogens (immunoassay G01N33/53)
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6832: Enhancement of hybridisation reaction
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Disclosed are compositions, reagents, methods, kits and systems for improving un-fixing or decrosslinking of fixed biological particles, fixed membrane-bound particles, fixed cells, nuclei and/or the biomolecules (e.g., nucleic acids, RNA) of fixed cells or nuclei. Processing of nucleic acids and barcoding nucleic acids are disclosed. Methods for increasing amounts and quality of un-fixed biomolecules (e.g., nucleic acids, RNA) from fixed cells or nuclei are disclosed. Polymers like polyethylene glycol (PEG) increase the amount and quality of ribonucleic acid (RNA) obtained from un-fixed cells or nuclei. Disclosed are methods for using un-fixed cells/nuclei and biomolecules from un-fixed cells/nuclei in various assays. Polymers like PEG increase the efficiency of nucleic acid polymerase reactions (e.g., DNA polymerase, reverse transcriptase) in presence of un-fixing agents. In some examples, PEG increases reverse transcriptase activity, in the presence of proteases, when PEG is included in the reaction.

## Claims

### Claim 1

A method for processing a nucleic acid molecule, comprising:
a) providing a partition comprising: (i) a fixed biological particle or a fixed membrane bound particle comprising a nucleic acid molecule comprising a nucleic acid sequence, (ii) a nucleic acid barcode molecule, and (iii) a cleaving agent;
b) subjecting said partition to a condition sufficient to generate a nucleic acid molecule comprising said nucleic acid sequence coupled to said nucleic acid barcode molecule;
c) releasing said nucleic acid molecule comprising said nucleic acid sequence coupled to said nucleic acid barcode molecule from said partition to generate a released nucleic acid molecule comprising said nucleic acid sequence coupled to said nucleic acid barcode molecule; and
d) subjecting said released nucleic acid molecule comprising said nucleic acid sequence coupled to said nucleic acid barcode molecule to a condition sufficient to extend said nucleic acid barcode molecule, using said nucleic acid sequence as a template and performed in presence of polyethylene glycol, to generate a barcoded nucleic acid molecule.

### Claim 2 (depends on 1)

The method of claim 1, wherein said nucleic acid molecule is a cross-linked nucleic acid molecule, a cross-linked ribonucleic acid (RNA) molecule, or a cross-linked messenger RNA (mRNA) molecule.

### Claim 3 (depends on 2)

The method of claim 2, wherein b) comprises: (i) generating an unlinked nucleic acid molecule from said cross-linked nucleic acid molecule and (ii) allowing said unlinked nucleic acid molecule to couple with said nucleic acid barcode molecule.

### Claim 4 (depends on 1)

The method of claim 1, wherein said cleaving agent is a protease and, optionally, wherein d) is performed in presence of a protease inhibitor.

### Claim 5 (depends on 1)

The method of claim 1, wherein the partition further comprises: (iv) a catalyst and/or (v) polyethylene glycol.

### Claim 6 (depends on 1)

The method of claim 1, wherein the fixed biological particle or fixed membrane bound particle is a fixed single cell, a fixed single nucleus, a cell, a nucleus, or a virus.

### Claim 7

(canceled)

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The method of claim 1, wherein b) comprises heating said partition, and wherein the method further optionally comprises, subsequent to b) and prior to c), cooling said partition or allowing said partition to cool.

### Claim 10

(canceled)

### Claim 11

(canceled)

### Claim 12

(canceled)

### Claim 13 (depends on 1)

The method of claim 1, wherein d) comprises using a reverse transcriptase to extend said nucleic acid molecule barcode molecule, and optionally wherein said reverse transcriptase comprises RNase activity.

### Claim 14

(canceled)

### Claim 15 (depends on 1)

The method of claim 1, wherein said nucleic acid barcode molecule comprises a capture sequence configured to anneal to a nucleic acid molecule of said fixed biological particle or said fixed membrane bound particle.

### Claim 16 (depends on 1)

The method of claim 1, further comprising:
appending an additional sequence to said barcoded nucleic acid molecule, optionally wherein said additional sequence is a poly-C sequence, and wherein said appending is performed by a ligase or a polymerase or a reverse transcriptase or by using a splint nucleic acid molecule; and
optionally subjecting said partition to a condition sufficient to hybridize a template switching oligonucleotide (TSO) to said additional sequence and extending said barcoded nucleic acid molecule to generate an extended barcoded nucleic acid molecule comprising a sequence complementary to said TSO.

### Claim 17

(canceled)

### Claim 18

(canceled)

### Claim 19

(canceled)

### Claim 20

(canceled)

### Claim 21

(canceled)

### Claim 22

(canceled)

### Claim 23

(canceled)

### Claim 24 (depends on 1)

The method of claim 1, wherein said nucleic acid barcode molecule is coupled to a support, optionally wherein said support is a bead or optionally wherein said nucleic acid barcode molecule is coupled to said support by a labile moiety.

### Claim 25

(canceled)

### Claim 26

(canceled)

### Claim 27 (depends on 1)

The method of claim 1, wherein said partition is a droplet or a well.

### Claim 28

(canceled)

### Claim 29

(canceled)

### Claim 30 (depends on 1)

The method of claim 1, further comprising: e) sequencing said barcoded nucleic acid molecule or an amplification product thereof.

### Claim 31 (depends on 1)

The method of claim 1, further comprising:
providing a plurality of partitions
prior to a), partitioning a plurality of fixed biological particles or a plurality of fixed membrane bound particles into the plurality of partitions;
subsequent to b) and prior to c), said plurality of partitions comprise a plurality of nucleic acid molecules coupled to nucleic acid barcode molecules; and
subsequent to c), pooling said plurality of nucleic acid molecules coupled to said nucleic acid barcode molecules from said plurality of partitions.

### Claim 32

(canceled)

### Claim 33

(canceled)

### Claim 34

(canceled)

### Claim 35 (depends on 1)

The method of claim 1, further comprising prior to a), fixing a biological particle or a membrane bound particle to generate said fixed biological particle or said fixed membrane bound particle, wherein said fixing comprises use of a fixation agent, and optionally wherein said fixation agent comprises paraformaldehyde.

### Claim 36

(canceled)

### Claim 37

(canceled)

### Claim 38

(canceled)

### Claim 39

(canceled)

### Claim 40

(canceled)

### Claim 41

(canceled)

### Claim 42

(canceled)

### Claim 43

(canceled)

### Claim 44

(canceled)

### Claim 45

A method, comprising:
a) un-fixing or partially un-fixing fixed cells, nuclei or tissues using an un-fixing agent; and
b) synthesizing a complementary single-stranded DNA using a nucleic acid template from the un-fixed or partially un-fixed cells, nuclei or tissues and a reverse transcriptase (RT),
wherein a) and/or b) is conducted in presence of a polyethylene glycol (PEG).

### Claim 46 (depends on 45)

The method of claim 45, wherein the un-fixing agent removes crosslinks formed by an aldehyde, including paraformaldehyde and/or glutaraldehyde; an NHS ester, including N-Hydroxysuccinimide; or an imidoester, that are present in biomolecules in the fixed cells or nuclei.

### Claim 47 (depends on 45)

The method of claim 45, wherein the un-fixing agent has protease activity and/or wherein the un-fixing agent includes a catalyst.

### Claim 48

(canceled)

### Claim 49

(canceled)

### Claim 50

(canceled)

### Claim 51

(canceled)

### Claim 52 (depends on 45)

The method of claim 45, wherein a) is performed in a partition.

### Claim 53 (depends on 45)

The method of claim 45, further, comprising: isolating a nucleic acid from the un-fixed cells or nuclei.

### Claim 54

(canceled)

### Claim 55

(canceled)

### Claim 56

(canceled)

### Claim 57

(canceled)

### Claim 58

(canceled)

### Claim 59

(canceled)

### Claim 60

(canceled)

### Claim 61

(canceled)

### Claim 62

(canceled)
